Thomas Hope

This early-stage study tests two types of targeted radiation therapy (177Lu-PSMA-617 and 225Ac-PSMA-617) in 45 men with high-risk prostate cancer who are scheduled for prostate removal surgery. The goal is to see which therapy delivers more radiation to the tumor and how it affec…

This study tests a new radioactive tracer called FAP-2286 to see if it can better detect cancer that has spread in adults with solid tumors. About 191 participants will receive the tracer and then have a PET scan. The goal is to measure how safe the tracer is and how well it high…

This study compares a newer type of scan (I-124 PET/CT) with the usual scans (I-123 and I-131) to see if it can better detect where thyroid cancer has spread in the body. About 62 people with thyroid cancer who have had their thyroid removed will get both scans. The goal is to se…

This program gives patients at UCSF access to a special PET scan using 18F-fluorocholine to find parathyroid adenomas—small, benign tumors that cause high calcium levels. It is for people aged 13 and older with confirmed primary hyperparathyroidism. The goal is to better locate t…

This study tests a special imaging agent called FET that helps spot brain tumors on PET scans. FET collects in cancer cells, making it easier to see if a tumor has come back after treatment or how aggressive it is. About 199 people with known or suspected brain tumors will take p…